MedPath

Propiverine

Generic Name
Propiverine
Brand Names
Mictoryl
Drug Type
Small Molecule
Chemical Formula
C23H29NO3
CAS Number
60569-19-9
Unique Ingredient Identifier
468GE2241L

Overview

Propiverine is a widely used antimuscarinic drug with a mixed mode of action in the treatment of symptoms associated with overactive bladder (OAB) . Overactive bladder (OAB) is a chronic condition of the lower urinary tract characterized by urinary urgency, increased frequency of urination, and nocturia (frequent waking during the night to urinate). OAB has a negative impact on quality of life and may lead to leakage and inconvenient urinary accidents , . Overactive bladder syndrome affects millions of elderly individuals in the United States and shows equal prevalence in men and women. The impact of OAB on quality of life is sometimes devastating, especially to elderly patients with other medical conditions . Propiverine hydrochloride is a bladder detrusor muscle relaxant drug with dual antimuscarinic and calcium-modulating properties for the treatment of OAB .

Indication

Indicated for symptomatic treatment of urinary incontinence and/or increased urinary frequency and urgency in patients with overactive bladder (OAB) . Propiverine may also be used in patients with neurogenic bladder as a result of spinal cord injury .

Associated Conditions

  • Urinary Incontinence (UI)
  • Urinary Urgency
  • Increased frequency of urination

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/07/01
N/A
Active, not recruiting
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
2025/06/19
N/A
Active, not recruiting
Furkan Adem Canbaz
2019/02/18
Not Applicable
Completed
2018/07/27
N/A
Completed
2014/11/19
Phase 4
Completed
2013/12/31
N/A
Completed
2013/09/16
Not Applicable
Completed
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
2012/02/10
Phase 3
Completed
2012/01/19
Phase 3
Completed
Lee's Pharmaceutical Limited
2009/05/15
Phase 4
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
Mictonorm 15mg Tablet
SIN13235P
TABLET, COATED
15.000 mg
2/22/2007

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
MICTORYL PEDIATRIC
02460289
Tablet - Oral
5 MG
4/13/2017
MICTORYL
02460262
Capsule (Controlled-Delivery) - Oral
30 MG
5/8/2017
MICTORYL
02460270
Capsule (Controlled-Delivery) - Oral
45 MG
5/8/2017

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.